Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hetero Research Foundation presents antiviral agents

Jan. 22, 2016

Bispecific antibodies neutralize both Zaire and Sudan Ebola virus strains

Jan. 22, 2016

Daiichi Sankyo develops LRS inhibitors

Jan. 21, 2016

Spero Therapeutics describes antibacterials

Jan. 21, 2016

Profectus BioSciences initiates phase I testing of a vectored Ebola virus vaccine

Jan. 20, 2016

Sunshine Lake Pharma reports anti-HCV NS5B inhibitors

Jan. 20, 2016

DNAzymes can be used for molecular probes to detect specific bacterial strains

Jan. 20, 2016

First patient dosed in phase I trial evaluating TP-271

Jan. 20, 2016

FDA expands age indication for GSK's Hiberix

Jan. 19, 2016

Biological immunomodulator displays bi-phasic treatment response in preclinical HBV infection model

Jan. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...